Bristol Myers Squibb Announces $4.1B Deal for Turning Point Therapeutics
By Daniel Shvartsman Investing.com -- Pharmaceutical large Bristol Myers Squibb Firm (NYSE:) introduced a $4.1 billion deal for Turning Level ...
Tag: 41B
By Daniel Shvartsman Investing.com -- Pharmaceutical large Bristol Myers Squibb Firm (NYSE:) introduced a $4.1 billion deal for Turning Level ...